Enact Holdings Inc.
ACT
NASDAQ·Financial Services·Insurance - Specialty·Mkt cap $6.9B
$49.27
▼ -0.48%
P/E
10.37
Mkt Cap
$6.9B
52-Wk Range
$34.64–$50.56
52-Week Range
$34.64 - $50.56
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 26.9% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Comprehensive mortgage risk assessment
- Strong underwriting expertise
- Established lender relationships
- Advanced risk modeling technology
Bear Case
1 risk
- Low volatility (beta 0.5).
Growth
Stable outlook
Housing market recovery
Value
Fairly valued vs Property & Casualty Insurance peers
Momentum
Strong
+19.4% over 3m
Quality
Excellent
Excellent business quality
Dividend
Modest
1.83% yield
Smart-money signal
Who's buying ACT right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 4, 2026
AUG 5, 2026
Reported EPS of $1.26 vs $1.19 consensus (+5.9% surprise). Revenue of $317.3M vs $315.8M expected (+0.5%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+5.9%
Revenue trend · last 8Q
—
+2%
+6%
+3%
+0%
+8%
+2%
+4%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$297.3M
$289.7M
$306.9M
$304.6M
$311.5M
$311.5M
$312.1M
$317.3M
Margins · last 8Q
Gross
0.0%
Operating
55.9%
Profit
55.1%
Wall Street consensus
2 analysts · 50% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
50%
Hold
50%
Sell
0%
Median Price Target
—
Latest: RBC Capital · Jun 25, 2026
vs Industry
How ACT stacks vs Insurance - Specialty
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related